| 2026-08-06 | Bestätigt | TD Cowen | Buy |
| 2026-05-07 | Bestätigt | TD Cowen | Buy |
| 2026-01-13 | Eingeleitet | Raymond James | Mkt Perform |
| 2025-11-10 | Hochstufung | Guggenheim | Neutral → Buy |
| 2025-11-07 | Bestätigt | TD Cowen | Buy |
| 2025-10-21 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-10-15 | Hochstufung | BMO Capital Markets | Underperform → Market Perform |
| 2025-10-01 | Hochstufung | Jefferies | Hold → Buy |
| 2025-08-18 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-08-07 | Bestätigt | TD Cowen | Buy |
| 2025-07-09 | Hochstufung | Jefferies | Underperform → Hold |
| 2025-07-08 | Hochstufung | KeyBanc Capital Markets | Underweight → Sector Weight |
| 2025-07-07 | Hochstufung | BNP Paribas Exane | Neutral → Outperform |
| 2025-06-18 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-06-17 | Herabstufung | KeyBanc Capital Markets | Sector Weight → Underweight |
| 2025-06-11 | Herabstufung | Jefferies | Hold → Underperform |
| 2025-05-22 | Herabstufung | BMO Capital Markets | Market Perform → Underperform |
| 2025-05-22 | Herabstufung | BNP Paribas Exane | Outperform → Neutral |
| 2025-04-23 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-04-17 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-03-12 | Herabstufung | Jefferies | Buy → Hold |
| 2025-02-28 | Bestätigt | TD Cowen | Buy |
| 2025-01-10 | Hochstufung | UBS | Neutral → Buy |
| 2025-01-07 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2024-12-19 | Eingeleitet | TD Cowen | Buy |
| 2024-11-22 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-11-08 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2024-11-07 | Herabstufung | Guggenheim | Buy → Neutral |
| 2024-02-27 | Herabstufung | Janney | Buy → Neutral |
| 2024-01-04 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-12-19 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-12-15 | Eingeleitet | Jefferies | Buy |
| 2023-11-21 | Eingeleitet | Mizuho | Buy |
| 2023-11-02 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2023-11-02 | Herabstufung | Northland Capital | Outperform → Market Perform |
| 2023-10-20 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-10-20 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-10-04 | Herabstufung | Truist | Buy → Hold |
| 2023-08-30 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-08-03 | Hochstufung | Janney | Neutral → Buy |
| 2023-04-18 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-04-14 | Resumed | CapitalOne | Overweight |
| 2023-04-03 | Resumed | Morgan Stanley | Overweight |
| 2023-03-10 | Eingeleitet | Citigroup | Neutral |
| 2023-03-02 | Eingeleitet | Scotiabank | Sector Outperform |
| 2023-01-25 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2023-01-06 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2022-12-01 | Eingeleitet | Janney | Neutral |
| 2022-11-15 | Eingeleitet | Deutsche Bank | Buy |
| 2022-10-20 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2022-09-28 | Eingeleitet | Northland Capital | Outperform |
| 2022-08-05 | Eingeleitet | Barclays | Overweight |
| 2022-07-19 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-06-29 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-05-02 | Resumed | Truist | Buy |
| 2022-01-24 | Bestätigt | Truist | Buy |
| 2021-12-20 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-10-01 | Eingeleitet | BMO Capital Markets | Outperform |
| 2021-09-10 | Eingeleitet | Needham | Buy |
| 2021-09-01 | Eingeleitet | Wolfe Research | Outperform |
| 2021-07-14 | Resumed | Credit Suisse | Outperform |
| 2021-06-25 | Eingeleitet | Stephens | Overweight |
| 2021-06-16 | Bestätigt | Morgan Stanley | Overweight |
| 2021-06-03 | Resumed | Guggenheim | Buy |
| 2021-04-20 | Eingeleitet | Evercore ISI | Outperform |
| 2021-04-16 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-04-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-03-23 | Hochstufung | Goldman | Neutral → Buy |
| 2021-03-22 | Eingeleitet | Susquehanna | Positive |
| 2021-03-10 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-03-10 | Hochstufung | UBS | Sell → Neutral |
| 2021-03-01 | Hochstufung | CapitalOne | Equal Weight → Overweight |
| 2021-02-25 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2021-01-20 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2021-01-12 | Eingeleitet | Truist | Buy |
| 2020-12-17 | Eingeleitet | CapitalOne | Equal Weight |
| 2020-10-27 | Herabstufung | UBS | Neutral → Sell |
| 2020-10-07 | Eingeleitet | Piper Sandler | Neutral |
| 2020-09-30 | Herabstufung | Goldman | Buy → Neutral |
| 2020-09-29 | Bestätigt | BofA Securities | Buy |
| 2020-07-13 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-02-19 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-01-16 | Eingeleitet | JP Morgan | Overweight |
| 2019-08-20 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2019-06-18 | Hochstufung | Goldman | Neutral → Buy |
| 2019-05-16 | Eingeleitet | Barclays | Overweight |
| 2019-04-25 | Bestätigt | BofA/Merrill | Buy |
| 2018-09-11 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2018-08-13 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2018-08-03 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2018-04-06 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2018-03-07 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2018-03-02 | Eingeleitet | ROTH Capital | Buy |
| 2018-02-12 | Eingeleitet | Credit Suisse | Outperform |
| 2017-03-22 | Hochstufung | UBS | Neutral → Buy |
RUN
